Brock B ONeil
Overview
Explore the profile of Brock B ONeil including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
251
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lopez A, Al Hussein Al Awamlh B, Huang L, Zhao Z, Koyama T, Hoffman K, et al.
Urol Oncol
. 2024 Dec;
43(4):271.e19-271.e28.
PMID: 39690079
Objectives: Compare functional outcomes and treatment-related regret over 10 years in Spanish- and English-speaking Hispanic men compared to non-Hispanic men following treatment of localized prostate cancer. Methods And Materials: Data...
2.
Nguyen D, Barocas D, Zhao Z, Huang L, Koyama T, Al Hussein Ai Awamlh B, et al.
J Cancer Surviv
. 2024 Oct;
PMID: 39400687
Purpose: There is limited evidence of tobacco smoking's effect on cancer survivors' quality of life (QOL) and function. As the natural history of localized prostate cancer (PCa) is protracted, there...
3.
Choudry M, Dindinger-Hill K, Ambrose J, Horns J, Vehawn J, Gill H, et al.
Cancer Med
. 2024 Mar;
13(5):e7058.
PMID: 38477496
Introduction: Patients living in rural areas have worse cancer-specific outcomes. This study examines the effect of family-based social capital on genitourinary cancer survival. We hypothesized that rural patients with urban...
4.
Al Hussein Al Awamlh B, Wallis C, Penson D, Huang L, Zhao Z, Conwill R, et al.
JAMA
. 2024 Jan;
331(4):302-317.
PMID: 38261043
Importance: Adverse outcomes associated with treatments for localized prostate cancer remain unclear. Objective: To compare rates of adverse functional outcomes between specific treatments for localized prostate cancer. Design, Setting, And...
5.
Gore J, Follmer K, Reynolds J, Nash M, Anderson C, Catto J, et al.
Urol Oncol
. 2023 Dec;
42(4):116.e17-116.e21.
PMID: 38087711
Background: Academic and community urology centers participating in a pragmatic clinical trial in non-muscle-invasive bladder cancer completed monthly surveys assessing restrictions in aspects of bladder cancer care due to the...
6.
Lange S, Vehawn J, Choudry M, Ambrose J, Cluff C, Haaland B, et al.
Urol Pract
. 2023 Sep;
11(1):110-115.
PMID: 37747942
Introduction: No professional society guidelines recommend PSA screening in men younger than age 40; however, data suggest testing occurs at meaningful rates in this age group. The purpose of this...
7.
Tallman J, Wallis C, Huang L, Zhao Z, Penson D, Koyama T, et al.
Prostate Cancer Prostatic Dis
. 2023 Mar;
26(1):214.
PMID: 36914851
No abstract available.
8.
Tallman J, Wallis C, Zhao Z, Huang L, Penson D, Koyama T, et al.
Prostate Cancer Prostatic Dis
. 2023 Mar;
26(4):809.
PMID: 36890265
No abstract available.
9.
Tallman J, Wallis C, Zhao Z, Huang L, Penson D, Koyama T, et al.
Prostate Cancer Prostatic Dis
. 2022 Dec;
26(4):787-794.
PMID: 36482081
Background: Benign prostatic hyperplasia, lower urinary tract symptoms, and prostate cancer often co-occur. Their effect on urinary function is an important consideration regarding prostate cancer treatment choices. While prostate volume...
10.
De B, Pasalic D, Barocas D, Wallis C, Huang L, Zhao Z, et al.
J Urol
. 2022 Nov;
208(6):1239.
PMID: 36349918
No abstract available.